Eiger Announces Appointment of Biopharmaceutical Industry Veteran David Apelian, MD, PhD, MBA to its Board of Directors

Company Prepares to Advance Orphan Disease Pipeline PALO ALTO, Calif., June 14, 2017 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of therapies for rare dise... Biopharmaceuticals, Personnel Eiger BioPharmaceuticals, Hepatitis Delta Virus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news